Search

Journal BJUI Compass

51. Enzalutamide + androgen deprivation therapy (ADT) versus flutamide + ADT in Japanese men with castration‐resistant prostate cancer: AFTERCAB study. Issue 1 (20th August 2021)

Authors:
Uemura, Hiroji; Kobayashi, Kazuki; Yokomizo, Akira; Hinotsu, Shiro; Horie, Shigeo; Kakehi, Yoshiyuki; Naito, Seiji; Nonomura, Norio; Ogawa, Osamu; Oya, Mototsugu; Suzuki, Kazuhiro; Saito, Atsushi; Uno, Satoshi; Akaza, Hideyuki
Journal:
BJUI Compass
Issue:
Volume 3:Issue 1(2022)
Page Start:
26
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

52. EQUINOXE study: Impact of relational cohesion and sexuality on the quality of life of patients treated with gonadotropin‐releasing hormone agonist for prostate cancer. Issue 1 (19th October 2021)

Authors:
Droupy, Stéphane; Colson, Marie‐Hélène; Pello‐Leprince‐Ringuet, Nathalie; Perrot, Valérie; Descazeaud, Aurélien
Journal:
BJUI Compass
Issue:
Volume 3:Issue 1(2022)
Page Start:
45
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

56. Feasibility of aspirin and/or vitamin D3 for men with prostate cancer on active surveillance with Prolaris® testing. Issue 6 (11th June 2022)

Authors:
Dinneen, Eoin; Shaw, Gregory L.; Kealy, Roseann; Alexandris, Panos; Finnegan, Kier; Chu, Kimberley; Haidar, Nadia; Santos‐Vidal, Sara; Kudahetti, Sakunthala; Moore, Caroline M.; Grey, Alistair D. R.; Berney, Daniel M.; Sahdev, Anju; Cathcart, Paul J.; Oliver, R. Timothy D.; Rajan, Prabhakar; Cuzi...
Other Names:
Cuzick Jack investigator.; Madaan Sanjeev investigator.; Pati Jhumur investigator.; Chowdhury Abdul M. investigator.; Birch Brian R. P. investigator.; Dudderidge Timothy J. investigator.; Moore Caroline M. investigator.; Grey Alistair D. R. investigator.; Shaw Gregory L. investigator.; Jefferson ...
Journal:
BJUI Compass
Issue:
Volume 3:Issue 6(2022)
Page Start:
458
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

58. FGFR2/3 genomic alterations and response to Enfortumab Vedotin in metastatic urothelial carcinoma. Issue 2 (10th November 2021)

Authors:
Adib, Elio; El‐Zarif, Talal; Jain, Rohit K.; Skelton, William P.; Freeman, Dory; Curran, Catherine; Akl, Elie W.; Nassar, Amin H.; Ravi, Praful; Mantia, Charlene; Kwiatkowski, David J.; Choueiri, Toni K.; Sonpavde, Guru P.
Journal:
BJUI Compass
Issue:
Volume 3:Issue 2(2022)
Page Start:
169
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗